IMRX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

IMRXImmuneering Corp

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

IMRXImmuneering Corp

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IMRX2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±23.8%▼−6.84%×0.29

Q2 FY26±18.2%▼−0.23%×0.01

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedIMRX realized, solidLLY realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedspan: IMRX 86d · LLY 267dSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

IMRXImmuneering Corp

3.76▲+2.17%· post 3.76· delayed

Mkt cap$238.1MRevenue—Revenue—

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,416.80· delayed

After hoursNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 4 '26delayed

IMRXImmuneering Corp

LLYELI Lilly & Co

3.76▲+2.17%post 3.76delayed

Price

1,417.89▲+0.60%post 1,416.80delayed

$238.1M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

IMRX3.76▲+2.17%vsLLY1,417.89▲+0.60%After hoursNov 4 '26delayed